VIVES is a multi-sector fund that invests in projects with a positive societal impact
IntoPIX is an independent and innovative technology provider with world-class expertise and knowledge in video processing and compression, cryptography, high performance computing and microelectronics...
e-Xstream develops unique non-linear multi-scale material and structure modeling that addresses the composite material needs of suppliers and end-users. e-Xstream designs and manufactures innovative,...
CISSOID is the leader in high temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme...
Pierre-Antoine Mariage, co-CEO Botalys :
"VIVES trusted us at an early stage. In addition to their financial investment, they offer us a regular and wise coaching from their experts while respecting...
Pierre Drion, business angel :
"For almost 20 years I have been passionate about what is called biotech. This led me to invest in several companies and mainly university spin-offs. In this context, I...
Denis Périquet, CEO Tessares :
"VIVES supports real innovation projects, while understanding that those projects need time to grow from the academic research phase to a commercial success. Team...
Promethera® Biosciences SA, société internationale pionnière dans le domaine des thérapies cellulaires et le traitement de maladies du foie, a aujourd’hui annoncé des changements au sein de son équipe
La société belge de biotechnologie ViroVet a annoncé aujourd'hui la mise à disposition de son expertise, de son personnel de recherche et d'une partie de son centre de recherche pour soutenir la
Données cliniques initiales attendues au 1S 2021
Cambridge, MA et Gosselies, Belgique - 27 février 2020 - iTeos Therapeutics Inc., une société privée de biotechnologie au stade clinique développant